GHSI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GHSI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Guardion Health Sciences's Trailing 12-Month Free Cash Flow is $-3.25 Mil, and Market Cap is $12.27 Mil. Therefore, Guardion Health Sciences's FCF Yield % for today is -26.49%.
The historical rank and industry rank for Guardion Health Sciences's FCF Yield % or its related term are showing as below:
During the past 9 years, the highest FCF Yield % of Guardion Health Sciences was -4.38%. The lowest was -229.87%. And the median was -43.54%.
Guardion Health Sciences's FCF Margin % for the quarter that ended in Mar. 2024 was -25.17%.
The historical data trend for Guardion Health Sciences's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardion Health Sciences Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
FCF Yield % | Get a 7-Day Free Trial | -37.54 | -21.32 | -67.81 | -81.06 | -64.23 |
Guardion Health Sciences Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
FCF Yield % | Get a 7-Day Free Trial | -97.17 | -16.59 | -32.60 | -77.42 | -26.06 |
For the Drug Manufacturers - Specialty & Generic subindustry, Guardion Health Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Guardion Health Sciences's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Guardion Health Sciences's FCF Yield % falls into.
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Guardion Health Sciences's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as
FCF Yield % | = | Free Cash Flow | / | Market Cap |
= | -4.374 | / | 6.8097816 | |
= | -64.23% |
Guardion Health Sciences's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as
FCF Yield % | = | Free Cash Flow | * | Annualized Factor | / | Market Cap |
= | -0.755 | * | 4 | / | 11.589544 | |
= | -26.06% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardion Health Sciences FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Thank you for viewing the detailed overview of Guardion Health Sciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Katharine Joan Cox | officer: Chief Accounting Officer | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Janet Hall | officer: CEO & President | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Bradley Louis Radoff | 10 percent owner | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
Family Foundation Radoff | other: See Footnote 1 | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
Michaela Griggs | director | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Bret Scholtes | director, officer: Chief Executive Officer | 2105 CITY WEST BLVD., SUITE 500, HOUSTON TX 77042 |
Donald A Gagliano | director | 131 CARDINAL AVE, SAN ANTONIO TX 78209 |
Jeffrey S Benjamin | officer: Chief Accounting Officer | 3885 CRESTWOOD PARKWAY, SUITE 550, DULUTH GA 30096 |
Craig Sheehan | officer: Chief Commercial Officer | 15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128 |
Andrew C Schmidt | officer: Chief Financial Officer | 1700 CARNEGIE AVE, SUITE 100, SANTA ANA CA 92705 |
Kelly Anderson | director | C/O TOMI ENVIRONMENTAL SOLUTIONS, INC., 9454 WILSHIRE BLVD., R-1, BEVERLY HILLS CA 90212 |
David W Evans | director, officer: Chief Scientific Officer | 4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117 |
Tamara A Evans | 10 percent owner | 4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117 |
Vincent J Roth | officer: General Counsel and Secretary | 15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128 |
Robert N Weingarten | director | 5439 LOCKHURST DRIVE, WOODLAND HILLS CA 91367 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-19-2022
By GuruFocusNews GuruFocusNews • 06-09-2022
By GuruFocusNews GuruFocusNews • 06-11-2022
By GuruFocusNews GuruFocusNews • 06-15-2022
By Value_Insider Value_Insider • 11-14-2022
By GlobeNewswire GlobeNewswire • 01-06-2023
By sperokesalga sperokesalga • 05-15-2023
By Stock market mentor Stock market mentor • 01-06-2023
By PurpleRose PurpleRose • 07-15-2022
By GuruFocusNews GuruFocusNews • 06-25-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.